Alzheimer's Research Roundtable

Alzheimer's Assocation Research only
All of
  • Go to
  • Research Center
  • AAIC
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Roundtable

"I have been attending the Research Roundtable over the past three years and always look forward to these meetings. This is the best meeting forum around for Alzheimer's disease drug developers"

Research Roundtable members seek to facilitate the development and implementation of new treatments for Alzheimer's disease by collectively addressing obstacles to research and development, clinical care and public health education.

About the Research Roundtable

The Alzheimer's Association Research Roundtable is a consortium of scientists from the pharmaceutical, biotechnology, diagnostics, imaging and cognitive testing industries, and senior staff and advisors from the Association. Begun in 2003 with four sponsors, the Research Roundtable now includes more than 20 corporate sponsors, each of whom sends several senior scientists to the Roundtable to benefit from the state-of-the-field scientific presentations, collegial interactions and networking opportunities. Additional attendees include investigators from academia and such government organizations as the U.S. Food and Drug Administration; its European equivalent, the European Medicines Agency; and the National Institutes of Health.

Sharing expertise worldwide

Through the Research Roundtable, the Alzheimer's Association brings together scientists from around the world to discuss key areas in Alzheimer's science. The Roundtable convenes twice each year for a two-day presentation and discussion of specific topics within Alzheimer's research. Topics are selected from a list proposed and voted on by members.

Once a topic is selected, invitations to speakers are extended by a subcommittee, comprised of Research Roundtable members and Association science staff.

Roundtable members explore a broad range of Alzheimer's science topics, including:

  • New data and technologies that may improve the diagnosis of Alzheimer's disease, especially in its earliest and mildest stages.
  • Neuropsychological testing, genetic factors, and biochemical and neuroimaging biomarkers that could contribute to an earlier and more accurate Alzheimer's diagnosis.
  • Lessons learned about clinical trial design that may help shape future clinical trials of drugs aimed at slowing or stopping the progression of Alzheimer's.
  • The pros and cons of various scales as outcomes measures of clinical trials.

The outputs of Roundtable meetings are published as articles in the Alzheimer's Association's journal, Alzheimer's & Dementia®.

Back to top

Current 2014 members

Amgen Astellas
Astra Zeneca Biogen
Boehringer Bracket
Cytox Eisai
Forest Research Institute Forum
GE Grifols
Janssen Lilly
NavIdea Novartis
Pfizer Primal
Psychology Software Roche
Sanofi Takeda

Funding research

The Research Roundtable also sponsors Alzheimer's Association grants. The chosen project is named Research Roundtable Sponsored Grant and the principal investigator of the project is invited to give a progress report at a Roundtable meeting.

Visit our Grants page to learn more about Association research funding.

Back to top

Join the Research Roundtable

We invite companies to join the thought leaders in Alzheimer's research at the Research Roundtable. Sponsorship terms are for 12 months beginning on the date of a signed agreement.

For more information, please contact: Jay Thompson, Senior Associate Director Corporate Initiatives at 312.335.5192 or